Myriad Genetics, Inc. (MYGN) Stock Analysis

Free AI-powered analysis and research for Myriad Genetics, Inc. stock

Sector: Healthcare

Analyze Myriad Genetics, Inc. (MYGN) Stock

Myriad Genetics, Inc. (MYGN) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into MYGN stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for Myriad Genetics, Inc. stock.

📰 Latest Update

Myriad Genetics shares fall 7.1% after Piper Sandler downgrade

Tue, September 1, 2026 at 1:03 PM UTC 4 min read

Myriad Genetics (MYGN) shares dropped 7.1% following a downgrade by Piper Sandler, which raised concerns about the company's growth prospects and competitive positioning in the genetic testing market. This downgrade may signal potential challenges ahead, prompting investors to reassess their positions in light of the shifting market dynamics. The decline reflects broader investor sentiment and could impact future stock performance as the company navigates these challenges.

Read full article →

Why Analyze Myriad Genetics, Inc. (MYGN) with StockIQ?

• ✅ Free AI-powered analysis of Myriad Genetics, Inc. (MYGN) stock
• ✅ Real-time technical indicators for Myriad Genetics, Inc. stock
• ✅ Comprehensive risk assessment for MYGN
• ✅ No credit card required

People also watch